Aldeyra Therapeutics Inc (ALDX)
3.925
-0.02
(-0.38%)
USD |
NASDAQ |
Apr 26, 16:00
4.10
+0.18
(+4.46%)
After-Hours: 20:00
Aldeyra Therapeutics Cash from Operations (Quarterly): 0.5004M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.5004M |
| September 30, 2023 | -8.025M |
| June 30, 2023 | -13.36M |
| March 31, 2023 | -9.444M |
| December 31, 2022 | -11.23M |
| September 30, 2022 | -12.57M |
| June 30, 2022 | -19.96M |
| March 31, 2022 | -12.87M |
| December 31, 2021 | -11.58M |
| September 30, 2021 | -8.434M |
| June 30, 2021 | -9.072M |
| March 31, 2021 | -13.47M |
| December 31, 2020 | -8.317M |
| September 30, 2020 | -6.238M |
| June 30, 2020 | -7.579M |
| March 31, 2020 | -15.36M |
| December 31, 2019 | -11.23M |
| September 30, 2019 | -8.315M |
| June 30, 2019 | -12.81M |
| March 31, 2019 | -12.63M |
| December 31, 2018 | -7.968M |
| September 30, 2018 | -7.689M |
| Date | Value |
|---|---|
| June 30, 2018 | -6.246M |
| March 31, 2018 | -7.955M |
| December 31, 2017 | -5.018M |
| September 30, 2017 | -4.706M |
| June 30, 2017 | -5.312M |
| March 31, 2017 | -4.187M |
| December 31, 2016 | -3.910M |
| September 30, 2016 | -3.504M |
| June 30, 2016 | -3.253M |
| March 31, 2016 | -4.481M |
| December 31, 2015 | -3.005M |
| September 30, 2015 | -2.861M |
| June 30, 2015 | -1.602M |
| March 31, 2015 | -1.844M |
| December 31, 2014 | -1.607M |
| September 30, 2014 | -1.211M |
| June 30, 2014 | -0.8945M |
| March 31, 2014 | -1.064M |
| December 31, 2013 | -0.6011M |
| September 30, 2013 | -0.5167M |
| June 30, 2013 | -0.2907M |
| March 31, 2013 | -0.298M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-19.96M
Minimum
Jun 2022
0.5004M
Maximum
Dec 2023
-10.49M
Average
-11.23M
Median
Dec 2019
Cash from Operations (Quarterly) Benchmarks
| AbbVie Inc | 4.753B |
| United Therapeutics Corp | 150.70M |
| Heron Therapeutics Inc | 2.455M |
| Esperion Therapeutics Inc | -37.06M |
| FibroGen Inc | -18.32M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | -1.012M |
| Free Cash Flow | -30.33M |
| Free Cash Flow Per Share (Quarterly) | 0.0085 |
| Free Cash Flow Yield | -13.11% |